CTLA4 and acute myeloid leukemia: CTLA4 mRNA levels were increased in PBMCs of AML patients compared to healthy controls, in addition surface CTLA-4 protein was detectable in >50% and cytoplasmic CTLA-4 in nearly 100% of patients [58, 63, 64].